cblEType of homocystinuria due to methionine synthase reductase deficiency: Functional correction by minigene expression
- 23 February 2005
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 25 (3) , 239-247
- https://doi.org/10.1002/humu.20131
Abstract
The cblE type of homocystinuria is a rare autosomal recessive disorder caused by impaired reductive activation of methionine synthase. Although earlier biochemical studies proposed that the methionine synthase enzyme might be activated by two different reducing systems, mutations were reported in only the methionine synthase reductase gene (MTRR) in cblE patients. The pathogenicity of MTRR mutations, however, has not yet been tested functionally. We report on nine patients of European origin affected by the cblE type of homocystinuria. They presented between 2 weeks and 3 years of age (median age 4 weeks) with anemia, which was macrocytic in only three patients, and with neurological involvement in all but two cases. Bone marrow examination performed in seven patients showed megaloblastic changes in all but one of them. All patients exhibited moderate to severe hyperhomocysteinemia (median plasma total homocysteine [Hcy] 92 μmol/L, range 44–169), while clearly reduced methionine was observed only in four cases. Pathogenic mutations were identified in both parental alleles of the MTRR gene in all patients. Five known (c.903+469T>C, c.1361C>T, c.1459G>A, c.1557‐4_1557+3del7, and c.1622_1623dupTA) and three novel mutations (c.7A>T, c.1573C>T, and c.1953‐6_1953‐2del5) were detected. Importantly, transfection of fibroblasts of cblE patients with a wild‐type MTRR minigene expression construct resulted in a significant approximately four‐fold increase of methionine synthesis, indicating correction of the enzyme defect. Our study shows a link between a milder predominantly hematological presentation and homozygosity for the c.1361C>T mutation, but no other obvious genotype‐phenotype correlation. The identification of mutations in the MTRR gene, together with restoration of methionine synthesis following MTRR minigene expression in cblE cells confirms that this disease is caused by defects in the MTRR gene. Hum Mutat 25:239–247, 2005.Keywords
This publication has 25 references indexed in Scilit:
- Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery diseaseMolecular Genetics and Metabolism, 2003
- Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitaminsAmerican Journal of Hypertension, 2002
- RNA surveillance: unforeseen consequences for gene expression, inherited genetic disorders and cancerTrends in Genetics, 1999
- Purification of Soluble Cytochrome b 5 as a Component of the Reductive Activation of Porcine Methionine SynthaseJournal of Biological Chemistry, 1998
- Folate‐responsive homocystinuria and megaloblastic anaemia in a female patient with functional methionine synthase deficiency (cblE disease)Journal of Inherited Metabolic Disease, 1997
- Defects in Auxiliary Redox Proteins Lead to Functional Methionine Synthase DeficiencyJournal of Biological Chemistry, 1997
- Human Methionine SynthaseJournal of Biological Chemistry, 1997
- Methionine and Serine Formation in Control and Mutant Human Cultured Fibroblasts: Evidence for Methyl Trapping and Characterization of Remethylation DefectsPediatric Research, 1997
- Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiencyMetabolism, 1988
- Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1987